App review
Diabetes:M review: a comprehensive all-in-one application with strong European market presence
Diabetes:M is a comprehensive diabetes self-management application with substantial features at a low price point. The application has strong presence in European markets and is gaining traction elsewhere. Carbohydrate counting is functional, the bolus-helper feature is configurable, and the CGM integration list is among the broadest in the segment. The application is not as polished as mySugr in markets where mySugr is the established choice, but it is a credible alternative.
At a glance
| Best for | Adults with diabetes in European markets who want a comprehensive all-in-one application; users who find mySugr's pricing unaffordable but want comparable functionality. |
|---|---|
| Pricing | Free tier; Pro subscription approximately $4 per month or $30 per year. |
| CGM integration | Multiple CGMs via partner integrations, Apple Health, Google Fit |
| FDA status | Not FDA-cleared as a medical device. Tracking tool with optional bolus-helper; verify current regulatory status in your jurisdiction. |
Strengths
- Comprehensive feature set at a low price point relative to comparable applications.
- Configurable bolus-helper (parameters set by the user; clinician sign-off recommended).
- Broad CGM integration list.
- Strong reporting and export.
Limitations
- Less polished user interface than the segment leaders.
- No photo-based portion estimation.
- Bolus-helper is not registered as a medical device in major markets known to the editorial team; verify regional status.
- Database is adequate but not the strongest in the segment.
Editorial summary
Diabetes:M is the application the editorial team recommends to adults with diabetes who want a comprehensive feature set at a low price point. The application is particularly common in European markets and offers most of the features users associate with the segment leaders: glucose logging, carbohydrate logging, configurable bolus-helper, CGM integration, and reporting.
The application is not as polished as mySugr, particularly in the bolus-helper workflow, where mySugr’s MDR-registered configuration in select EU markets gives mySugr a regulatory advantage. For users in jurisdictions where mySugr’s regulated configuration is not available, or for users for whom mySugr’s pricing is prohibitive, Diabetes:M is a credible alternative.
Carbohydrate counting in Diabetes:M
The carbohydrate-counting workflow is functional. The internal database is adequate — comparable to Glucose Buddy, less differentiated than Cronometer. The application does not offer photo-based portion estimation. As elsewhere, mixed-dish accuracy is bounded by user portion estimation.
Users with substantial mixed-dish exposure should consider pairing Diabetes:M (for the integrated logbook and bolus-helper) with PlateLens (for the carbohydrate estimate) in a two-app workflow.
Bolus-helper
Diabetes:M’s bolus-helper takes user-configured parameters (insulin-to-carbohydrate ratio, correction factor, target range, insulin-on-board duration) and produces a recommended bolus. The parameters must be set by the user with the prescribing clinician’s input; the application does not, and must not, recommend its own ratios or factors.
The bolus-helper is not, to the editorial team’s knowledge, registered as a medical device in major markets. Users should verify the current regulatory status in their jurisdiction before relying on the recommended bolus as a regulated dosing aid. In practice, the editorial team treats Diabetes:M’s bolus-helper as a calculator that surfaces the user’s clinician-set parameters, not as a regulated dosing aid.
Limits
- No photo-based portion estimation.
- Bolus-helper regulatory status varies by region.
- User interface less polished than the segment leaders.
- Not FDA-cleared as a medical device.
References
- American Diabetes Association. (2026). Standards of Care in Diabetes — 2026: Section on technology and self-management. Diabetes Care.
- Endocrine Society. (2024). Clinical Practice Guideline: Diabetes technology for adults with type 1 diabetes. Journal of Clinical Endocrinology & Metabolism.
- O’Connor, L. M., & Caunt, S. (2024). Mobile applications for self-management in type 2 diabetes: a scoping review. Diabetic Medicine.
- Schmidt, S., et al. (2024). Real-world use of bolus calculator applications in adults with type 1 diabetes. Journal of Diabetes Science and Technology.
- Patterson, R. E., et al. (2025). Real-world MAPE of mobile-application-based carbohydrate counting: an observational cohort. Diabetes Technology & Therapeutics.